Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning

References

Page 1

	Year	Citations
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report Madan Jagasia, Hildegard Greinix, Mukta Arora, Biology of Blood and Marrow Transplantation Solid Organ TransplantationImmunologyPathologySurgeryChronic Gvhd	2014	5.2K
1994 Consensus Conference on Acute GVHD Grading. Donna Przepiorka, Daniel Weisdorf, Peyton Martin, PubMed	1995	5.1K
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly, Clinical Infectious Diseases	2008	4.9K
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report Alexandra H. Filipovich, Daniel J. Weisdorf, Steven Z. Pavletic, Biology of Blood and Marrow Transplantation	2005	3.5K
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT Mohamed L. Sorror, Michael B. Maris, Rainer Storb, Blood	2005	2.9K
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, New England Journal of Medicine	2012	2K
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali, New England Journal of Medicine	2012	1.8K
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa, New England Journal of Medicine	2010	1.2K
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Journal of Clinical Oncology	2010	1K
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Blood	2009	954

Page 1